Z15.81Billable
Genetic susceptibility to multiple endocrine neoplasia [MEN]
- Chapter
- 21. Factors influencing health status and contact with health services
- Category
- Z15
- Effective date
- October 1, 2026
Related codes in category Z15
Z15Genetic susceptibility to diseaseZ15.0Genetic susceptibility to malignant neoplasmZ15.01Genetic susceptibility to malignant neoplasm of breastYesZ15.02Genetic susceptibility to malignant neoplasm of ovaryYesZ15.03Genetic susceptibility to malignant neoplasm of prostateYesZ15.04Genetic susceptibility to malignant neoplasm of endometriumYesZ15.05Genetic susceptibility to malignant neoplasm of fallop(s)YesZ15.06Genetic susceptibility to malignant neoplasm of dgstv sysZ15.060Genetic susceptibility to colorectal cancerYesZ15.068Genetic susceptibility to other malig neoplasm of dgstv sysYesZ15.07Genetic susceptibility to malig neoplasm of urinary tractYesZ15.09Genetic susceptibility to other malignant neoplasmYes
Frequently asked questions
What is ICD-10 code Z15.81?
Z15.81 is an ICD-10-CM diagnosis code for Genetic susceptibility to multiple endocrine neoplasia [MEN].
Is Z15.81 a billable code?
Yes. Z15.81 is billable and specific enough to be used on a claim.
What ICD-10-CM chapter is Z15.81 in?
Z15.81 falls under Chapter 21: Factors influencing health status and contact with health services.
When did Z15.81 become effective?
Z15.81 has been effective since October 1, 2026, per the CMS/CDC ICD-10-CM annual release.
What other codes are related to Z15.81?
Z15.81 belongs to category Z15, which includes 12 other codes — see the related codes list on this page.
ICD-10-CM data maintained by CDC/CMS (public domain). Always verify codes with authoritative sources before making coding or billing decisions.